The Van Nuys businessman entered the federal court process after his arrest, pleaded not guilty, and received bond while prosecutors advanced a sweeping hospice case alleging false Medicare claims, identity misuse, kickbacks, and criminally derived spending.
WASHINGTON, DC, August 23, 2026 — Oren David Shachar was arraigned in United States District Court in Los Angeles after federal agents arrested the Van Nuys businessman in a 16-count Medicare hospice fraud case involving four Southern California providers.
The June 18 hearing moved the prosecution from a sealed investigative phase into open adversarial proceedings, where formal charges, release conditions, discovery obligations, motion practice, and an eventual trial or other lawful resolution can be addressed under judicial supervision.
Prosecutors allege Shachar helped generate approximately $27,731,000 in false hospice claims and obtained about $26,908,000 from Medicare, but the arraignment did not determine whether any claim was fraudulent or whether any defendant committed a crime.
Shachar, Abraham Shin, and Jeannie Choi retain the constitutional presumption of innocence, while the government must prove every element of each applicable offense beyond a reasonable doubt with admissible evidence, not allegations alone.
June 18 brought the indictment into open court
The grand jury returned the indictment on June 16 under case number 2:26-cr-00393-SB, and the Justice Department’s official Southern California announcement says Shachar and Shin were arrested, made initial appearances, and were arraigned two days later in Los Angeles.
Contemporaneous news coverage of the Los Angeles prosecution reported that Shachar and Shin entered not-guilty pleas, while a federal magistrate judge ordered both men released on bond as the criminal case proceeded toward pretrial litigation before any trial.
Those procedural events occurred quickly because federal rules ordinarily require an arrested defendant to appear before a judicial officer without unnecessary delay, receive information about the accusations, address representation, and obtain a decision concerning detention or conditional release.
Nothing about that compressed sequence establishes that prosecutors proved their case, because an initial appearance and arraignment protect orderly process while leaving factual disputes, evidentiary challenges, witness credibility, and the ultimate question of guilt entirely unresolved.
Initial appearance and arraignment perform different functions
During an initial appearance, a judicial officer ordinarily confirms the defendant’s identity, explains core rights, addresses counsel, describes the charges or indictment, and considers whether the person should remain detained or can safely return to the community under conditions.
An arraignment performs the narrower but essential task of formally presenting the indictment and receiving a plea, thereby defining the accusations that the defendant must answer while creating a record from which later deadlines and proceedings can develop.
When both events occur on the same day, the combination does not mean the court evaluated the government’s complete evidence, heard trial witnesses, resolved disputed facts, or made findings comparable to those required for conviction after trial.
The hearing instead marks a controlled beginning, converting a grand-jury-approved indictment into an active prosecution involving a named defendant who can examine the government’s case, invoke procedural protections, and prepare a response through counsel.
A not-guilty plea preserves every contested issue
Shachars reported that the not-guilty plea placed every charged element in dispute and required prosecutors to prove the alleged agreement, claim executions, identity use, financial transaction, kickback payments, and beneficiary-identifier sale through evidence satisfying the criminal burden of proof.
That plea also preserved opportunities to challenge the indictment’s legal theories, contest the admissibility or interpretation of records, cross-examine witnesses, retain experts, present defense evidence, and argue that prosecutors cannot connect particular conduct to the required criminal intent.
A not-guilty plea should not be interpreted as a procedural delay or prediction about the final outcome, because it is the ordinary mechanism by which an accused person demands the trial protections guaranteed within the federal criminal justice system.
Although some federal cases later resolve through plea agreements, cooperation, dismissals, or narrowed charges, no such development should be presumed from an arraignment, and any future change would require its own formal process and careful judicial review.
Bond release keeps the defendant under court authority
The magistrate judge’s decision to release Shachar on bond allowed him to remain outside detention while the case continued, but release neither dismissed the indictment nor signaled that the court accepted or rejected the government’s underlying allegations.
Federal release decisions focus upon appearance and community-safety considerations, often using conditions tailored to identified risks, while the specific obligations governing Shachar should be described only from accessible court orders rather than assumed from practices in unrelated prosecutions.
A defendant released before trial remains subject to the court’s jurisdiction and must comply with every imposed requirement, attend scheduled proceedings, communicate appropriately through counsel, and avoid conduct that could trigger modification or revocation of release.
The bond ruling therefore created a supervised procedural status, balancing the presumption favoring liberty before conviction against legitimate judicial concerns while allowing defense preparation to continue beyond the immediate constraints of custodial detention within the district.
Los Angeles is the prosecution’s federal forum
The indictment places the alleged conduct within Los Angeles County and the Central District of California, connecting the prosecution to hospice businesses, bank activity, beneficiaries, records, witnesses, and transactions located across the greater Southern California region.
Shachar was publicly identified as a Van Nuys resident, while the four hospices named by prosecutors operated in Valley Glen, Montclair, Encino, and Glendale, creating a geographic pattern spanning several communities under one alleged ownership and operational structure.
Venue identifies the proper judicial district for trying charged conduct, whereas subject-matter jurisdiction reflects the federal nature of statutes involving Medicare, health care fraud, identity theft, financial proceeds, kickbacks, and federally protected beneficiary information in this prosecution.
The Los Angeles arraignment consequently did more than provide a courtroom location, because it established where discovery disputes, motions, trial preparation, evidentiary rulings, jury selection, and any eventual adjudication would ordinarily be managed unless later orders changed that framework.
Sixteen counts were presented through one indictment
Shachar is named in all 16 counts, beginning with one conspiracy allegation and continuing through eight alleged health care fraud executions, three aggravated identity theft counts, one proceeds transaction, two kickback-payment accusations, and one beneficiary-identifier sale.
Choi and Shin face a narrower group of shared counts involving the alleged conspiracy, three selected fraud executions, and three connected identity offenses, reflecting prosecutors’ claim that their participation began during a later portion of the wider timeline.
Each count requires separate analysis because a jury could accept the evidence supporting one claim or transaction while rejecting another, and association with an alleged conspiracy does not automatically establish responsibility for every act described elsewhere in the indictment.
The arraignment placed that complete count structure before Shachar, but it did not convert grand-jury accusations into trial evidence, since the charging document has not itself been tested through authentication, competing testimony, cross-examination, or defense presentation.
Four hospice businesses anchor the allegations
Prosecutors allege Shachar owned, controlled, or operated Gentle Touch Hospice Care, Oxford Hospice Care, Art of Hospice, and Holly Trinity Hospice at different times beginning as early as October 2019 and continuing through the charged period.
The government says those entities submitted false claims from February 2021 through March 2026 for services that were medically unnecessary, connected to unlawfully procured referrals, or never provided because certain purported beneficiaries had already died, according to prosecutors.
Medicare enrollment applications, corporate filings, provider numbers, reimbursement records, bank accounts, payroll files, clinical charts, and internal communications may help establish how the companies operated, although ownership alone cannot prove knowledge concerning every disputed claim or employee action.
The defense may contest whether the providers delivered legitimate hospice care, whether clinical certifications reflected reasonable judgments, whether Shachar directed particular submissions, and whether conduct attributed to employees, marketers, physicians, or nurses can lawfully be assigned to him.
The payment ratio will shape the financial case
The indictment alleges the four hospices billed approximately $27,731,000 and received approximately $26,908,000, meaning Medicare paid nearly 97 percent of the submitted amount before investigators and prosecutors assembled the criminal case now pending in Los Angeles.
That ratio provides a striking measure of alleged public loss, yet it does not independently prove that every reimbursed service was false, because prosecutors must establish the fraudulent character, causation, knowledge, and attribution required for charged offenses.
Selected claims within Counts Two through Nine represent only a small portion of the overall billing total, giving prosecutors concrete transactions for trial while leaving the broader monetary narrative dependent upon additional records, witnesses, and financial analysis.
If convictions occur, disputed loss calculations could affect sentencing, restitution, and forfeiture arguments, although those later questions would follow rather than precede determinations about guilt and could involve substantial disagreements over legitimate services or attributable amounts.
Living beneficiaries were allegedly recruited with benefits
Prosecutors allege Shachar paid some beneficiaries as much as $400 monthly to remain enrolled, while additional incentives purportedly included groceries, alcohol, personal-care supplies, medical equipment, televisions, massages, furniture, and reclining chairs provided during continued hospice participation.
The indictment also describes referral rewards between $100 and $200 for beneficiaries who recruited others, alongside compensation that sometimes paid marketers approximately $700 for each living patient during every month that Medicare continued receiving hospice claims.
Those allegations are consequential because hospice enrollment ordinarily concerns a person certified as terminally ill and can affect Medicare coverage for treatment intended to cure the terminal condition, making informed consent and independent clinical judgment especially important.
Prosecutors must prove that challenged payments carried a prohibited purpose and related to federally reimbursable referrals, while defense counsel may dispute recipients, descriptions, intent, authorization, witness accounts, or whether certain support represented legitimate patient care rather than inducements.
Deceased beneficiaries drive the identity allegations
The indictment alleges that personal information belonging to deceased people moved from a funeral-home employee through marketers to Shachar, including names, Social Security numbers, Medicare identifiers, death information, physician details, medical histories, and next-of-kin records within linked files.
Prosecutors say participants used that information to create backdated documents portraying deceased individuals as evaluated, certified as terminally ill, and admitted before death, thereby making later claims appear to describe genuine periods of hospice service eligible for payment.
Counts Ten through Twelve charge aggravated identity theft in connection with three selected health care fraud executions, requiring proof that protected means of identification were knowingly used without lawful authority during and in relation to qualifying predicate crimes.
Amicus International’s examination of identity-theft methods and stolen personal records provides broader context for understanding how combined identifiers can support elaborate fraud when institutional data, medical information, and government numbers appear mutually consistent across separate systems.
The indictment describes an allegedly fabricated clinical timeline
Prosecutors contend that relatives of deceased beneficiaries were contacted for additional information, while hospital records created before death were gathered and incorporated into paperwork intended to make post-death hospice enrollment resemble legitimate end-of-life care within Medicare systems.
Electronic metadata, document-creation timestamps, signature records, communications, source files, and testimony from clinicians or relatives could become particularly important because the alleged fraud depends upon whether records were prepared when they claim or reconstructed afterward through later forensic review.
The defense may argue that dates reflect delayed documentation, administrative correction, incomplete files, misunderstood workflows, or conduct performed without Shachar’s knowledge, while prosecutors may characterize the same evidence as coordinated fabrication designed to obtain payment from Medicare.
Arraignment resolved none of those competing interpretations, leaving the courtroom process to determine which records are authentic, who created or approved them, what each participant understood, and whether the government can establish criminal intent beyond a reasonable doubt.
A Rolls-Royce transaction creates a separate financial count
Count Thirteen alleges that a $15,000 wire moved on or about September 20, 2024, from Holly Trinity Hospice’s JPMorgan Chase account as partial payment toward a lease-to-own down payment for a Rolls-Royce Phantom luxury automobile arrangement.
Prosecutors characterize the transferred money as criminally derived property exceeding $10,000 and traceable to health care fraud, while the government must prove the qualifying transaction, unlawful source, interstate-commerce connection, and Shachar’s required knowledge at the time.
The indictment does not allege that the single wire purchased the entire automobile or disclose every financing detail, so accurate reporting should preserve the narrower claim involving partial payment rather than expand it into an unsupported full-purchase narrative.
Luxury spending can become memorable evidence before a jury, but the defense may challenge tracing, ownership, purpose, prejudice, or alternative funding, while the court must ensure that symbolism never substitutes for proof satisfying each statutory element.
The final count alleges a beneficiary-number sale
Count Sixteen accuses Shachar of selling, arranging the sale, or distributing nine Medicare beneficiary identification numbers to an unnamed physician for $12,500 on or about March 6, 2025, without lawful authority to complete that transaction.
That accusation differs from the aggravated identity theft counts because it concerns an alleged commercial transfer of beneficiary numbers under the Anti-Kickback Statute, rather than identity use connected directly to three specified health care fraud executions.
Amicus International’s guidance distinguishing lawful identity changes from illicit identity construction underscores the essential difference between legitimate government-recognized procedures and unauthorized trading, fabrication, exploitation, or concealment involving another person’s protected identifiers for financial gain.
At trial, prosecutors would still need to establish that the transfer occurred, that Shachar knowingly participated, that the information involved qualifying Medicare identifiers, and that no lawful authority supported the alleged sale or distribution described by prosecutors.
Co-defendants entered the case on different timelines
The indictment alleges Shin joined the conspiracy no later than March 2025 and Choi joined no later than May 2025, while Shachar’s alleged conduct involving hospice operations and claims extends back to February 2021, according to prosecutors.
Shin was arrested, initially appeared, and was arraigned alongside Shachar on June 18, whereas prosecutors announced that Choi was arrested several days later and expected to make her first Los Angeles federal court appearance afterward under the same indictment.
Those differing dates matter because the government must prove each person’s knowledge and participation individually, even where conspiracy principles may allow certain acts or statements to become relevant against more than one defendant under federal evidentiary rules.
Separate lawyers may pursue different factual theories, challenge different witnesses, or seek severance if joint proceedings create legally significant prejudice, while prosecutors may argue that overlapping records and participants support one coordinated presentation before a jury.
Discovery will determine what lies beyond the indictment
The public indictment offers a detailed accusation, but discovery may contain substantially more material, including Medicare data, clinical charts, bank records, device extractions, messages, emails, death records, corporate documents, referral ledgers, interview reports, and witness statements.
Prosecutors must organize admissible evidence that connects those materials to particular counts and defendants, while also meeting constitutional and procedural disclosure duties involving information favorable to the defense or relevant to witness credibility under governing law.
Defense counsel can examine whether records are complete, accurately attributed, properly obtained, and presented in context, while experts may analyze hospice eligibility, billing rules, electronic metadata, handwriting, financial tracing, or the medical basis for terminal-illness certifications.
Because beneficiary files contain sensitive health and identity information, the court may need protective arrangements that permit meaningful defense access while reducing unnecessary public disclosure of private details belonging to patients, relatives, and deceased individuals throughout pretrial litigation.
Pretrial motions can reshape the case before trial
Future motions may challenge searches, electronic evidence, statements, expert testimony, co-conspirator communications, joinder, forfeiture theories, identity-count sufficiency, or potentially prejudicial material involving luxury spending and emotionally charged allegations about deceased beneficiaries at trial.
A defense motion does not establish that evidence was unlawfully obtained, just as a prosecution response does not establish admissibility, because the district judge must apply governing law to a developed record and explain consequential rulings.
Some decisions could narrow counts or exclude particular exhibits without resolving the overall case, while others could shape how prosecutors present complex Medicare evidence and how defendants contest separate roles within an alleged multi-year conspiracy.
The arraignment began the period in which these disputes can be framed, briefed, and decided, making the hearing a procedural gateway even though the most consequential legal arguments may occur weeks or months after Shachar’s first appearance.
The announced August trial date was an initial setting
The Justice Department’s June 23 announcement stated that Shachar and Shin were scheduled for trial on August 11, but criminal trial settings can change through later judicial orders, continuances, discovery needs, motion schedules, or findings concerning excludable time.
Readers should therefore distinguish the government’s publicly announced initial date from a guaranteed trial commencement, especially in a document-intensive prosecution involving three defendants, four companies, extensive Medicare data, medical records, and contested financial evidence before any final resolution.
The Speedy Trial Act protects prompt adjudication while recognizing defined periods that may be excluded from calculation, and judges must balance those statutory requirements against realistic preparation needs, fairness, court availability, and resolution of pending motions.
The authoritative schedule remains the federal docket and the court’s current orders, while any reported date should be accompanied by the practical recognition that complex criminal calendars frequently evolve as both sides assess evidence and litigation needs.
The case formed part of a national enforcement operation
Federal authorities announced charges against 455 defendants, including 90 physicians and other licensed professionals, across 56 federal districts and 45 states and territories in matters alleging more than $6.5 billion in fraudulent claims and significant patient harm.
The coordinated operation also involved more than $182 million in announced seizures of cash, luxury vehicles, jewelry, and other assets, together with payment suspensions, billing revocations, exclusions, civil settlements, and additional administrative enforcement measures across numerous jurisdictions.
Within Southern California, prosecutors announced ten defendants across cases involving Medicare hospice services, Medi-Cal prescriptions, laboratory testing, psychiatric evaluations, controlled-substance prescribing, and other alleged abuses of publicly supported health programs throughout the region.
That enforcement context explains why Shachar’s arraignment received national attention, but inclusion within a major takedown cannot lessen the government’s individualized burden or transform allegations against hundreds of unrelated defendants into evidence against him at trial.
Hospice compliance lessons extend beyond billing codes
The allegations illustrate why hospice compliance programs should integrate clinical eligibility, beneficiary consent, referral compensation, ownership disclosures, identity controls, bank activity, and high-value expenditures rather than examining each risk area through isolated reviews or occasional audits.
Administrators should require reliable documentation for terminal-illness certifications, verify that records reflect actual encounters, prohibit backdating that misrepresents events, and ensure clinicians can refuse unsupported paperwork without retaliation from owners, marketers, or supervisors within any provider.
Financial controls should document legitimate purposes for owner-related transfers, identify unusual referral payments, limit account authority, review transactions above defined thresholds, and compare company expenditures with reimbursement patterns and disclosed business relationships through independent compliance personnel.
Effective oversight also requires protected reporting channels, independent audits, prompt investigation of beneficiary complaints, and careful monitoring of vendors or marketers who possess access to death records, medical histories, Social Security numbers, Medicare identifiers, or state death data.
Patients and families remain central to the alleged harm
Improper hospice enrollment can affect more than program finances because beneficiaries may misunderstand eligibility requirements, terminal-illness certifications, comfort-focused treatment, or Medicare limitations involving services intended to cure the condition underlying their hospice election during that process.
Families of deceased beneficiaries can face a different injury when private information gathered during illness, death, and bereavement is allegedly purchased, transferred, backdated, and converted into billing records that later appear within criminal litigation as disputed evidence.
Legitimate hospice organizations also suffer reputational consequences when extraordinary allegations create generalized suspicion, despite the essential nursing, counseling, symptom management, spiritual support, and dignity that compliant providers deliver to eligible patients and their families across Southern California.
Careful coverage must therefore describe the alleged misconduct precisely, protect unnamed beneficiaries wherever possible, avoid stigmatizing lawful hospice care, and repeat that no defendant becomes guilty simply because prosecutors announce a disturbing or financially substantial theory.
Sentencing exposure cannot be calculated at arraignment
Health care fraud, the alleged proceeds transaction, and Anti-Kickback Statute offenses carry substantial potential penalties, while aggravated identity theft can require an additional consecutive prison term following conviction for a properly connected predicate offense under governing federal law.
Adding statutory maximums across 16 counts would not predict a real sentence, because federal judges consider conviction counts, grouping principles, loss findings, criminal history, role adjustments, victim impact, acceptance of responsibility, and broader statutory sentencing factors.
Restitution and forfeiture may also become contested if guilt is established, with disputes potentially addressing traceable proceeds, substitute assets, legitimate services, third-party interests, transaction values, and the amount of loss directly attributable to particular conduct after conviction.
At arraignment, however, those consequences remain conditional possibilities rather than present punishments, because Shachar has not been convicted and the court cannot impose a criminal sentence unless a lawful adjudication through trial or plea first establishes guilt.
The federal courtroom now controls the next chapter
As the case proceeds, prosecutors and defense lawyers may address discovery production, expert disclosures, scheduling, evidentiary motions, witness issues, plea discussions, trial preparation, and forfeiture questions under deadlines the court establishes or modifies throughout the litigation.
The government may attempt to connect Medicare reimbursements with allegedly ineligible beneficiaries, bought referrals, deceased identities, fabricated clinical files, corporate control, and luxury spending, while the defense can challenge every link within that proposed evidentiary chain.
Shachar’s June 18 arraignment mattered because it placed the accusations within a transparent judicial structure, provided an opportunity to enter a plea, established conditional release, and activated the protections governing a federal criminal prosecution.
The hearing was not a verdict, and the defining question remains unchanged as the Central District of California case moves forward: whether prosecutors can convert a detailed 16-count indictment into reliable proof establishing each charged offense beyond a reasonable doubt.
